Clinical Trial Update: Study to Assess Drug Levels and Safety of BMS-986278 in Healthy Participants and Participants With Different Degrees of Hepatic Impairment [Phase 1]

View source ↗

Summary

A Phase 1 trial update reporting study NCT06425198 evaluating drug levels and safety of BMS-986278 in healthy participants and individuals with hepatic impairme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Impairment

Drugs mentioned

• BMS-986278

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Hepatic Impairment, Healthy Participants | Phase 1 | Status: COMPLETED